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ABSTRACT
Major depressive disorder is a prevalent condition with high relapse rates. There is
evidence that cognitive reactivity is an important vulnerability factor for the
recurrence of depression. Mindfulness-based interventions are designed to reduce
relapse rates, with cognitive reactivity as one of the proposed working mechanisms.
In a randomised controlled trial we compared the effect of mindfulness-based
cognitive therapy (MBCT) with treatment-as-usual (TAU) on cognitive reactivity in
recurrently depressed patients (N = 115). Depressive symptoms, cognitive reactivity,
and mindfulness skills were assessed pre and post treatment. Patients in the MBCT
group reported a significantly greater reduction in cognitive reactivity than those in
the TAU group (d = .51). The reduction of cognitive reactivity appeared to mediate
the association between MBCT/TAU and decrease of depressive symptoms, using
pre and post scores. The current study provides evidence that MBCT reduces
cognitive reactivity and preliminary evidence that cognitive reactivity is a working
mechanism of MBCT.
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Despite evidence-based treatments for major
depression, residual depressive symptoms are very
common and relapse rates are high (Zajecka, Korn-
stein, & Blier, 2013). This means that not only recovery
from an initial depressive episode, but also reducing
the vulnerability to relapse is very important. Accord-
ing to the cognitive model of depression (Beck,
2008), one of the core factors that characterises
depressed individuals is the underlying negative
beliefs about themselves. These negative beliefs, for
example “If I make a mistake, this means I am a
failure”, are called dysfunctional attitudes. Importantly,
dysfunctional attitudes tend to persist latently, even
after remission from a depressive episode, and can
be easily activated by a sad mood (Scher, Ingram, &
Segal, 2005). The ease with which these dysfunctional
attitudes are activated by sad mood states is defined
as cognitive reactivity (Van der Does, 2002).
Cognitive reactivity is not only an important
factor in the onset (Kruijt et al., 2013) and mainten-
ance of depressive symptoms (Struijs, Groenewold,
Voshaar, & de Jonge, 2013), but especially important
for depressive relapse/recurrence. Patients who
experienced several depressive episodes reported
higher cognitive reactivity compared with patients
with just one previous episode (Elgersma et al.,
2015). In addition, in prospective studies, those
with higher post-treatment levels of cognitive reac-
tivity appeared to have an earlier relapse/recurrence
(Figueroa et al., 2015; Segal et al., 2006). However,
non-replications of the effect of cognitive reactivity
on relapse rates also exist (e.g. van Rijsbergen
et al., 2013).
There are two common methods for measuring
cognitive reactivity: the first consists of a mood
induction accompanied by a scale to measure
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dysfunctional beliefs (Segal et al., 2006); the second
consists of a self-report measure, the Leiden Index
of Depression Sensitivity Revised [LEIDS-R] (Van der
Does, 2002), asking the participant to indicate
typical reactions to a sad mood. The LEIDS-R
addresses cognitive reactions to a negative swing in
mood and has been shown to differentiate
between previously depressed and never-depressed
individuals (Van der Does, 2002).
As cognitive reactivity seems to be related to the
onset, maintenance, and recurrence of major
depression, it is worth investigating whether cognitive
reactivity can be reduced by psychological interven-
tions. Previous studies have shown that cognitive
behavioural therapy, but not pharmacological treat-
ment, results in a reduction in cognitive reactivity,
indicating that a reduction in cognitive reactivity is
not a sheer effect of a reduction of depressive symp-
toms (Segal et al., 2006).
Another promising candidate to reduce cognitive
reactivity in recurrent depression is Mindfulness-
Based Cognitive Therapy (MBCT). MBCT was designed
to prevent relapse in remitted depressed patients,
and combines elements of cognitive therapy and
mindfulness practices. The aim of MBCT is to teach
participants to experience emotions, thoughts, and
bodily sensations in a non-judgmental and compas-
sionate way. Participants learn to become more
aware of dysfunctional automatic patterns, such as
depressive rumination and cognitive avoidance, and
thereby to disengage from them (Segal, Williams, &
Teasdale, 2002). Thereby MBCT teaches the ability
to decentre from negative cognitive thoughts and
disengage from dysfunctional cognitive processes,
rather than to try to avoid them. MBCT has been
shown to reduce relapse rates for depression and
to effectively reduce residual depressive symptoms
as well as symptom severity in current depression
(Kuyken et al., 2016; Strauss, Cavanagh, Oliver, &
Pettman, 2014). Only recently, research has focused
more on the working mechanisms of MBCT (Gu,
Strauss, Bond, & Cavanagh, 2015; van der Velden
et al., 2015).
There is preliminary evidence that mindfulness-
based interventions might result in a reduction in
cognitive reactivity. Trait mindfulness skills seem to
be negatively correlated with cognitive reactivity in
university students (Raes, Dewulf, Van Heeringen, &
Williams, 2009, Study 1). In a non-randomised con-
trolled study, participants receiving MBCT showed a
greater reduction in cognitive reactivity than those
on a MBCT waiting list acting as controls (Raes et al.,
2009, Study 2). This finding was replicated in a study
offering a mindfulness-based intervention to econ-
omically disadvantaged individuals with depressive
symptoms. Cognitive reactivity decreased more over
the course of the mindfulness-based intervention
than during their own control period on the waiting
list (Van der Gucht, Takano, Van Broeck, & Raes,
2015). Furthermore, Raes et al. (2009) also found a
mediating effect of mindfulness skills on the relation-
ship between MBCT and cognitive reactivity, indicat-
ing that it is an increase in mindfulness skills, rather
than another non-specific therapy effect, that influ-
ences cognitive reactivity. Somewhat conflicting
results of the effect of MBCT on cognitive reactivity
have been found by Kuyken et al. (2010) in a sample
of remitted depressed patients. Participants receiving
MBCT showed increased cognitive reactivity post
treatment compared with those on maintenance anti-
depressant medication. It was, however, found that
although cognitive reactivity was predictive of
relapse/recurrence in the antidepressant medication
group, it no longer appeared to be predictive of
relapse/recurrence in the MBCT group, possibly indi-
cating a protective effect of MBCT. These somewhat
conflicting results could also be partly explained by
the fact that no baseline measure of cognitive reactiv-
ity was included and that the mood-induction method
was used, whereas the other two studies made use of
the LEIDS-R. In a systematic review on working mech-
anisms of mindfulness-based interventions Gu et al.
(2015) reported preliminary evidence of cognitive
reactivity as a possible working mechanism of the
effect of mindfulness-based interventions on symp-
toms, but also mentioned that more evidence is
needed.
In summary, there is ample evidence that MBCT
reduces relapse/recurrence rates in recurrent
depression, and some evidence that it might also
reduce residual depressive symptoms. One of the
possible working mechanisms is cognitive reactivity.
However, randomised controlled studies are needed
to further investigate this relationship. The aim of
this study is to fill this gap by investigating the
effect of MBCT on cognitive reactivity in remitted
depressed patients participating in a randomised con-
trolled trial comparing MBCT with treatment-as-usual
(TAU). It is hypothesised that MBCT will result in a
reduction in cognitive reactivity. Additionally, the
mediating effect of cognitive reactivity on depressive
symptoms will be investigated.
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Methods
Study population and procedure
This study is part of a randomised controlled trial com-
paring MBCT with TAU in patients with three or more
previous depressive episodes (N = 205) who were
either in remission or currently depressed (van Aalde-
ren et al., 2011). Measurements of cognitive reactivity
were available for 174 participants, which had not
been presented previously. In line with previous
studies (Kuyken et al., 2010), we only selected those
participants who were in full or partial remission at
baseline according to DSM-IV criteria (n = 115) and
excluded currently depressed participants (n = 59).
This decision was based on the fact that the LEIDS-R
was developed to be used in remitted depressed
patients. The instruction of the LEIDS-R to imagine a
slightly sad mood (see also measurement description)
probably leads to different effects in remitted versus
currently depressed patients. Exclusion criteria were:
(1) one or more previous (hypo)manic episodes
according to DSM-IV criteria; (2) current alcohol or
drug abuse; (3) urgent need for psychiatric treatment;
(4) problems hampering participation in a group; and
(5) problems hampering completion of the question-
naires. Participants taking antidepressant medication
were required to be on a stable dose for at least six
weeks prior to inclusion and were asked to maintain
this dose during the study period. After baseline
measurements were taken, participants were random-
ised to either the MBCT or the TAU group. Post-
measurements were taken after finishing MBCT
(MBCT group) or after a 3-month waitlist period (TAU
group).
The trial was approved by the local Medical Ethical
Committee. All participants gave written informed
consent. For a detailed description of all measure-
ments and a CONSORT flowchart see van Aalderen
et al. (2011).
Measures
Cognitive reactivity
The LEIDS-R (Van der Does, 2002) is a 34-item ques-
tionnaire measuring cognitive reactivity. It consists of
six subscales: hopelessness/suicidality; acceptance/
coping; aggression; control/perfectionism; harm
avoidance; and rumination. Participants are instructed
to imagine being in a sad or down but not seriously
depressed mood. An example item is “When I feel
sad, I spend more time thinking about what my
moods reveal about me as a person.” Participants
are asked to indicate on a 5-point scale (from “not at
all” to “very strongly”) whether the items reflect their
thoughts when experiencing a sad mood. Adequate
validity and reliability (Cronbach’s α = .92) are reported
(Solis, Antypa, Conijn, Kelderman, & Van der Does,
2016).
Depressive symptoms
The Hamilton Rating Scale for Depression (HAMD;
Hamilton, 1960) is a 17-item standardised interview
to measure the number and severity of depressive
symptoms on a scale of 0–52. The HAMD has good
psychometric properties with good internal consist-
ency (Cronbach’s α = .789) and high inter-rater
reliability (ICC = .937) (Trajković et al., 2011). Addition-
ally, self-reported levels of depression were investi-
gated with the Beck Depression Inventory (BDI). The
BDI is a 21-item self-report questionnaire to measure
depressive symptoms. The scores indicate the follow-
ing: 0–9 minimal depression; 10–18 mild depression;
19–29 moderate depression; 30–63 severe depression.
The BDI has good psychometric properties with a high
internal consistency (Cronbach’s α = .86) in psychiatric
patients (Beck, Steer, & Carbin, 1988).
Mindfulness skills
The Kentucky Inventory of Mindfulness (KIMS), is a
self-report questionnaire measuring mindfulness
skills with 39 items. The KIMS consists of four sub-
scales: observe; describe; act with awareness; and
accept without judgment. The KIMS has good psycho-
metric properties in recurrent depression (Baum et al.,
2010) with high internal consistency (subscales
ranging from Cronbach’s α = .72–.88).
Interventions
MBCT
Participants followed a standardised 8-week MBCT
training based on the manual of Segal et al. (2002).
The course consisted of weekly 2.5-hour group ses-
sions and 1 day (6 hours) of silent meditation, and
took place at the Radboudumc Centre for Mindfulness
located at the Radboud University Medical Center in
Nijmegen, the Netherlands. Treatment groups con-
sisted of 8–12 participants. Mindfulness trainers were
all experienced in working with groups of psychiatric
patients, had received at least 1.5 years of mindfulness
training and were experienced meditators with experi-
ence ranging from 2 to 20+ years.
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TAU
TAU consisted of a waitlist-control group receiving
mental health care from general practitioners or
specialised mental health care providers. Therefore,
TAU was a naturalistic condition consisting of (in
general high-quality) mental health care in the Nether-
lands, as for example, antidepressant medication or
individual psychotherapy. Participants were asked
not to change their medication during the study
period.
Statistical analyses
As the goal of the current study was to investigate
specific effects of MBCT on cognitive reactivity and
cognitive reactivity as a working mechanism, we
based our analysis on the per-protocol sample,
meaning that all participants attended at least four
sessions of MBCT. A linear mixed model was used to
compare post-measurement scores of cognitive reac-
tivity between the groups (MBCT vs. TAU), controlling
for baseline cognitive reactivity scores and baseline
depressive symptoms. To take clustering of the data
into account, we added a random group effect.
Cohen’s d effect size was computed. The same
model was used to verify previously examined (van
Aalderen et al., 2011) effects of condition on depress-
ive symptoms and mindfulness skills in this sample. To
explore whether reductions in cognitive reactivity
mediate the effect of condition (MBCT vs. TAU) on
depressive symptoms, a mediation analysis was con-
ducted with condition (MBCT vs. TAU) as independent
variable, change in depressive symptoms (from pre to
post MBCT/post TAU) as dependent variable, and
change in cognitive reactivity (from pre to post
MBCT/post TAU) as the hypothesised mediator. For
all change scores, standardised residualised change
scores were used (Kuyken et al., 2010). A nonpara-
metric bootstrapping method was used to assess the
indirect effect based on 1000 bootstrapped samples
using bias corrected and accelerated 95% confidence
intervals (BCa CI) as provided by Hayes [(2013) SPSS
PROCESS macro version 2.13]. To estimate the effect
size of the indirect effect, κ2 was computed which rep-
resents a “ratio to the maximum possible indirect
effect” (Preacher & Kelley, 2011). We also tested the
reverse model, using cognitive reactivity as the
outcome variable, and change in depressive symp-
toms as mediator (not predicted by the theoretical
model) to gain indications about causality in the
absence of temporal order of variables.
Results
Participant characteristics
The demographic and baseline characteristics of par-
ticipants are presented in Table 1. The groups
(MBCT/TAU) did not differ on most demographic
characteristics (gender, age, tertiary education,
number of previous depressive episodes), cognitive
reactivity, mindfulness skills, and depressive symp-
toms assessed with clinical interview (HAMD) at base-
line. However, participants in the MBCT group
reported a higher age of onset and somewhat lower
baseline levels of depressive symptoms on the self-
report questionnaire (BDI) than those in the TAU
group. No follow-up assessments were available for
two participants, so they were excluded from the ana-
lyses. They had significantly lower levels of cognitive
Table 1. Participant characteristics at baseline.
Total sample
(N = 115)
Mean (SD)
MBCT
(n = 63)
Mean (SD)
TAU
(n = 52)
Mean (SD) MBCT vs. TAUa
Demographic characteristics
Female 70.4% 68.3% 73% χ2(1) = .318, p = .573
Age (years) 47.53 (11.67) 46.84 (11.58) 48.37 (11.83) t(113) = .696, p = .488
Tertiary education 56% 58% 52% χ2(1) = .535, p = .465
Age of onset (years) 22.93 (10.70) 25.32 (11.44) 20.12 (9.09) t(109) = −2.67, p = .010b
Number of depressive episodes 6.86 (6.46) 7.18 (7.52) 6.47 (4.95) t(110) = −.577, p = .565
Symptoms at baseline
Cognitive reactivity (LEIDS-R) 79.46 (21.64) 81.48 (22.09) 77.02 (21.04) t(113) = −1.1, p = .274
Depressive symptoms-clinician (HAMD) 7.75 (5.08) 7.73 (5.47) 7.77 (7.17) t(113) = 0.41, p = .967
Depressive symptoms-self report (BDI) 13.12 (7.43) 11.76 (7.18) 14.77 (7.47) t(113) = 2.195, p = .030b
Mindfulness skills (KIMS) 74.13 (15.96) 75.24 (15.63) 72.76 (15.79) t(112) = −.837, p = .404
aDue to missing values the degrees of freedom differ between the analyses.
bSignificant at p < .05 level.
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reactivity on baseline (p = .02), but did not differ on
other measures.
Effect of MBCT vs. TAU on cognitive reactivity
Controlling for cognitive reactivity at baseline,
depressive symptoms at baseline (HAMD), and age
of onset, patients in the MBCT group showed signifi-
cantly less cognitive reactivity compared with the
TAU group at the end of treatment (group difference:
−11.02, 95% CI [−18.29, −3.75], F (1, 56.99) = 9.22, p
= .004). This effect represents a medium effect size,
Cohen’s d = .51. Excluding age of onset showed
similar results with a slightly larger effect size (group
difference: −13.08, 95% CI [−20.27, −5.88], F (1,
53.93) = 13.29, p = .001, Cohen’s d = .60). Controlling
for self-reported levels of depressive symptoms (BDI)
instead of clinical rated symptoms (HAMD) led to
similar effects. Paired sample t-tests revealed that
the MBCT condition showed a significant decrease in
cognitive reactivity over time (baseline M = 82.67,
post M = 72.47; t(60) = 4.52, p < .001), whereas the
TAU condition showed a significant increase in cogni-
tive reactivity (baseline M = 77.02, post M = 82.92;
t(51) =−2.23, p = .03).
Effect of MBCT vs. TAU on depressive
symptoms and mindfulness skills
Controlling for baseline scores and age of onset,
patients in the MBCT group showed significantly less
depressive symptoms (HAMD) (group difference:
−2.88, 95% CI [−4.76, −1.01], F (1,107) = 9.26, p = .003,
Cohen’s d = .57) and more mindfulness skills (group
difference: +13.96, 95% CI [9.331, 18.60], F (1, 105) =
35.702, p < .001, Cohen’s d = .87) compared with the
TAU group at the end of treatment. Similar effects on
depressive symptoms were observed when using
self-reported symptoms (BDI) instead of clinician-
rated symptoms (HAMD). Paired sample t-tests
revealed that the MBCT group showed a significant
decrease in depressive symptoms (baseline HAMD M
= 7.73, post HAMD M = 5.95, t(62) = 2.60, p = .012) and
significant increase in mindfulness skills (baseline
KIMS M = 75.36, post KIMS M = 86.68; t(60) =−5.87,
p < .001) whereas no changes in the TAU group
were observed (depressive symptoms: baseline HAMD
M = 7.77, post HAMD M = 8.83; p = .21; mindfulness
skills: baseline KIMS M = 72.76, post KIMS M = 70.77,
p = .16).
Mediation of depressive symptoms through
cognitive reactivity
Figure 1 depicts that condition had a significant effect
on change in cognitive reactivity, b =−.785, BCa CI
[−1.129, −.4418], change in cognitive reactivity in
turn had a significant effect on change in depressive
symptoms, b = .2294, BCa CI [.0358, .4231]. A signifi-
cant indirect effect (because zero is not included in
the 95% bias corrected confidence intervals) of con-
dition on change in depressive symptoms through
change in cognitive reactivity was observed, b =
−.1802, BootBCa CI [−.3705, −.0501]. This mediation
effect represents a medium effect size, κ2 = .09, BCa
CI [.0245, .1672]. Adding age of onset as a covariate
in the model, led to similar results with a significant
indirect effect, b =−.152 BCa CI [−.3221, −.0294].
When testing the reversed model, using change in
depressive symptoms as mediator and change in cog-
nitive reactivity as outcome, a significant but slightly
smaller indirect effect b = .124 BootBCa CI [−.2461,
−.0357], κ2 = .07, BCa CI [.0165, .1203] was observed.
Comparable effects in all mediation analyses were
observed when using self-reported depressive
Figure 1. Mediation model.
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symptoms (BDI) instead of symptoms rated by the
clinician (HAMD).
Discussion
The aim of this study was to investigate the effect of
MBCT on cognitive reactivity in recurrently depressed
patients in remission by using a randomised con-
trolled design. Our results show that participants of
the MBCT course demonstrated a significant reduction
in cognitive reactivity. In contrast, the participants of
the TAU group showed a significant increase in cogni-
tive reactivity, possibly indicating that the MBCT even
inhibited a natural increase in cognitive reactivity over
time. Furthermore, by using baseline and post-treat-
ment scores, we found that cognitive reactivity par-
tially mediated the effect on depressive symptoms.
Cognitive reactivity is an important factor in the
relapse/recurrence of depressive episodes (Beck,
2008; Figueroa et al., 2015). Therefore, it is important
to investigate which treatments can reduce cognitive
reactivity. The current results indicate that MBCT
might be more effective than TAU in reducing cogni-
tive reactivity. These results are in line with previous
non-randomised studies on the effect of mindful-
ness-based interventions on cognitive reactivity
(Raes et al., 2009; Van der Gucht et al., 2015). Our find-
ings are partly in contrast with results by Kuyken et al.
(2010) who found increased cognitive reactivity in par-
ticipants receiving MBCT. However, in their study, cog-
nitive reactivity was only related to relapse in the TAU
group, indicating that MBCT diminished the toxic
effect of the relationship between cognitive reactivity
and outcome. Importantly, in contrast to Kuyken et al.
(2010), we used the LEIDS-R instead of a mood-induc-
tion method. In a recent comment, Raes (2015) argued
that both methods possibly tap into different stages of
cognitive reactivity: the mood-induction method
would then measure dysfunctional thoughts more as
products of the mind, whereas the LEIDS-R specifically
investigates dysfunctional thinking as a mental
process in reaction to sad mood. This could partly
explain the different results, as MBCT is not aiming
at changing negative thoughts, but instead teaches
participants to react differently on negative mood or
initial dysfunctional thoughts.
Next to the effect of MBCT on cognitive reactivity as
an outcome, we found a mediating effect of cognitive
reactivity on the reduction in depressive symptoms
indicating that cognitive reactivity is a working mech-
anism of MBCT. This is in line with the theoretical
rationale of MBCT (Segal et al., 2002) and previous
findings (Gu et al., 2015). However, because we also
found a significant effect when testing the “reversed
model” (change in depressive symptoms mediating
change in cognitive reactivity), which would not be
predicted by the theoretical model of MBCT, con-
clusions should to be drawn with caution. Changes
in cognitive reactivity and depressive symptoms
seem to be interrelated when measured simul-
taneously. Longitudinal studies taking the temporal
order of variables into account are needed to investi-
gate the mediating effect of cognitive reactivity on
depressive symptoms.
Our results suggest that we might consider how to
strengthen the effect of MBCT on the reduction in cog-
nitive reactivity. We might, for example, emphasise
this mechanism even more in the psycho-educational
part of the MBCT course. Or we might increase the
practice of recognising negative mood and accompa-
nying thoughts during sitting meditations in the
second half of the course.
It is important to keep in mind, however, that cogni-
tive reactivity is not the only proposed working mech-
anism of MBCT. Other assumed mechanisms of change
in MBCT include for example mindfulness skills, self-
compassion, and psychological flexibility (Gu et al.,
2015). Kuyken et al. (2010) reported an interaction
between cognitive reactivity and self-compassion
skills, showing that in remitted depressed patients par-
ticipating in the MBCT course the negative prognostic
value of cognitive reactivity was mitigated by an
increase in self-compassion. The interaction between
different working mechanisms goes beyond the
scope of this study, but future research should focus
on disentangling the mechanisms of change of MBCT
and their interconnectedness by combining the
results of clinical randomised controlled trials with
other designs, such as dismantling designs, individual
difference designs, and experimental manipulations
(van der Velden et al., 2015). Thereby we could learn
more about the exact working mechanisms of MBCT
and could use this knowledge to improve the curricu-
lum and to be better able to predict which patients
would benefit most from MBCT.
Several strengths and limitations of this study
should be noted. First of all, the current study is one
of the first to specifically investigate the effects of
MBCT on cognitive reactivity in recurrently depressed
patients by using a randomised controlled design with
pre and post measures of cognitive reactivity, adding
important knowledge to the existing literature.
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Previous research has shown that levels of cognitive
reactivity predict relapse rates (Figueroa et al., 2015;
Kuyken et al., 2010). Figueroa et al. (2015) calculated
that a 20-point increase on the LEIDS-R resulted in a
10–15% higher chance of relapse. Relating their
figures to the current study would indicate that a
decrease in LEIDS-R of 11 points could have a substan-
tial effect on relapse rates, which should be further
investigated.
The limitations of this study give several directions
for future research. First, it should be noted that we
compared MBCT with a waitlist-control group receiv-
ing treatment as usual. Therefore, we do not know
how much of the effect is based on specific aspects
of mindfulness training or non-specific therapy
effects as peer support, hope or activation. In addition,
the proposed mediator and outcome were measured
simultaneously. Finding a variable statistically mediat-
ing an effect does not prove that it is a working mech-
anism, however, it is an important step in narrowing
down the possible variables of influence (Kazdin,
2007). Therefore, further longitudinal research is
needed to draw conclusions about causality.
Whereas the focus of the current study was on inves-
tigating cognitive reactivity as an outcome and
mediator of MBCT in a pre-post design, it would be
important to also investigate the predictive effect of
cognitive reactivity on relapse rates compared with a
control group in longitudinal designs. Finally, as
already noted, we used the LEIDS-R questionnaire
(Van der Does, 2002) to measure cognitive reactivity
rather than a mood-induction method (e.g. Kuyken
et al., 2010). The LEIDS-R investigates the ease in
which the participant reacts to a sad mood with dys-
functional beliefs. This is based on the assumption
that dysfunctional beliefs tend to persist in remitted
depressed patients (Scher et al., 2005) and can be acti-
vated by low mood states, which forms a vulnerability
factor for relapse. However, it is therefore not possible
with the current design to differentiate whether the
overall level of dysfunctional beliefs was reduced
after the MBCT or whether, in particular, the reaction
to a sad mood with dysfunctional beliefs decreased.
It would be valuable if future research investigated
the effect of MBCT on cognitive reactivity as well as
on overall levels of dysfunctional beliefs, independent
of mood or stress. In addition, future research directly
comparing the differences and similarities of the
LEIDS-R and the mood-induction method to measure
cognitive reactivity would be valuable. The significant
advantages of the LEIDS-R are its applicability in
clinical practice and that it excludes the possibility of
a failing mood induction; however, it requires insight
in one’s own cognitive processes. It would also be
useful if future research explored whether the LEIDS-
R successfully excludes social desirable answers and
answers merely based on knowledge obtained
during MBCT, rather than actual behaviour.
Taken together, the present study provides evi-
dence that MBCT reduces cognitive reactivity based
on a randomised controlled design in recurrently
depressed patients in remission. Furthermore, the
results add preliminary evidence to the existing litera-
ture about the theoretical assumption that the
reduction in cognitive reactivity decreases depressive
symptoms and is therefore a working mechanism of
MBCT.
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